Room Block Available
We are pleased to announce that for 6th Rare & Genetic Kidney Disease DD Summit we have a dedicated room block at the conference hotel, Hotel Commonwealth
We have a discounted nightly room rate of $379 until Monday 20 July
The booking reservation contact number is:1-617-933-5000 – please quote ‘41520260817RGKD’
Reservations must be made by Monday 20th July which is the cutoff date. However, please note due to high demand, rooms may sell out before the cutoff date so we do recommend you book your accommodation sooner rather than later.
Please email Darja Kielthy at Darja.kielthy@hansonwade.com if you have any questions or queries regarding the room block.
Venue
This year's event will be held in Boston, MA at the Hotel Commonwealth.
Important Note - Fraudulent Accommodation Booking Scams
We have been made aware that there are third-party companies contacting our conference attendees claiming to represent Hanson Wade Group with fraudulent hotel booking schemes.
Hanson Wade Group does not work with any third parties and accommodation information will only come directly from your Event Manager. For your safety, please only book your accommodation through official links provided by Hanson Wade Group. Learn more in our full accommodation policy: Accommodation Policy - Hanson Wade Group.
Explore the Agenda
Hear the latest breakthroughs in biomarker validation, surrogate endpoints, and clinical trial design through a packed agenda featuring 3 expert panel discussions, 3 pre-conference workshops, 2 interactive roundtables, and 12+ data-driven case study presentations.
Partner With Us
Position yourself alongside leading solution providers supporting rare and genetic kidney disease pipelines. Whether your expertise lies in preclinical or clinical research, novel biomarkers for diagnosis, stratification or monitoring, imaging, or genetic testing, ensure your brand is at the center of key conversations around clinical development, endpoint validation, and trial execution
Join Biopharma Experts
Engage with a uniquely focused audience of rare and genetic kidney disease decision-makers and be part of high-value conversations with like-minded attendees across all stages of drug development, building critical connections through dedicated networking opportunities